# A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer

> **NCT07457346** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 76 (estimated)

## Conditions studied

- Head and Neck Cancer Squamous Cell Carcinoma

## Interventions

- **DRUG:** cisplatin+ nab-paclitaxel +adebrelimab + imaxitinib

## Key facts

- **NCT ID:** NCT07457346
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-08-30
- **Final completion:** 2030-08-30
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457346, "A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07457346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*